Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6514
    -0.0022 (-0.33%)
     
  • OIL

    83.01
    +1.66 (+2.04%)
     
  • GOLD

    2,241.40
    +28.70 (+1.30%)
     
  • Bitcoin AUD

    108,560.44
    +2,781.95 (+2.63%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6038
    +0.0007 (+0.12%)
     
  • AUD/NZD

    1.0905
    +0.0026 (+0.23%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,254.69
    -26.15 (-0.14%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,807.37
    +47.29 (+0.12%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     

What Makes Anatara Lifesciences Limited (ASX:ANR) An Attractive Investment?

Anatara Lifesciences Limited (ASX:ANR) is a company with exceptional fundamental characteristics. Upon building up an investment case for a stock, we should look at various aspects. In the case of ANR, it is a company with strong financial health as well as a buoyant future outlook. Below is a brief commentary on these key aspects. For those interested in digger a bit deeper into my commentary, read the full report on Anatara Lifesciences here.

Flawless balance sheet with exceptional growth potential

ANR’s outstanding triple-digit top-line expansion forecasted for the near future is certainly eye-catching for investors on the hunt for growth. This is expected to flow down into an impressive return on equity of 29.6% over the next couple of years. ANR’s ability to maintain an adequate level of cash to meet upcoming liabilities is a good sign for its financial health. This indicates that ANR has sufficient cash flows and proper cash management in place, which is a crucial insight into the health of the company. Looking at ANR’s capital structure, the company has no debt on its balance sheet. It has only utilized funding from its equity capital to run the business, which is typically normal for a small-cap company. ANR has plenty of financial flexibility, without debt obligations to meet in the short term, as well as the headroom to raise debt should it need to in the future.

ASX:ANR Future Profit September 28th 18
ASX:ANR Future Profit September 28th 18

Next Steps:

For Anatara Lifesciences, I’ve put together three key factors you should further examine:

ADVERTISEMENT
  1. Historical Performance: What has ANR’s returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.

  2. Valuation: What is ANR worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether ANR is currently mispriced by the market.

  3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of ANR? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.